The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
The p53 family and programmed cell death
Open accessAbstract
The p53 tumor suppressor continues to hold distinction as the most frequently mutated gene in human cancer. The ability of p53 to induce programmed cell death, or apoptosis, of cells exposed to environmental or oncogenic stress constitutes a major pathway whereby p53 exerts its tumor suppressor function. In the past decade, we have discovered that p53 is not alone in its mission to destroy damaged or aberrantly proliferating cells: it has two homologs, p63 and p73, that in various cellular contexts and stresses contribute to this process. In this review, the mechanisms whereby p53, and in some cases p63 and p73, induce apoptosis are discussed. Other reviews have focused more extensively on the contribution of individual p53-regulated genes to apoptosis induction by this protein, whereas in this review, we focus more on those factors that mediate the decision between growth arrest and apoptosis by p53, p63 and p73, and on the post-translational modifications and protein–protein interactions that influence this decision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Likewise, a p53 deletion mutant containing only the first 214 Nterminal amino acid residues induces apoptosis and suppresses the transformation of rat embryo fibroblasts by several oncogenes, but it does not transactivate p53 target genes (Chen et al., 1996; Haupt et al., 1997).”
BackgroundThe Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 2×
“Although a physical interaction between BAX and p53 cannot be detected, p53 also induces BAX oligomerization and cytochrome C release (Chipuk et al., 2004).”
BackgroundYang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Dumont, P., Leu, J. I.-J., Della Pietra, A. C., George, D. L., & Murphy, M. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,273
Self-citationPost-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
Gong, J., Costanzo, A., Yang, H.-Q., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 930
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K. H., Han, J., Chittenden, T., Ihle, J. N., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00244-7 · Cited by 879
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
Ubiquitin and ubiquitin-like proteins as multifunctional signals
Welchman, R. L., Gordon, C., & Mayer, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1700 · Cited by 828
p53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · cited 1×
“Consistent with this premise, p53 poly-ubiquitylation acts as a protein destruction signal, whereas monoubiquitylation of p53 promotes nuclear export and mitochondrial localization (Li et al., 2003; Marchenko et al., 2007).”
Backgroundp63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 802
p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Self-citationCell Surface Trafficking of Fas: A Rapid Mechanism of p53-Mediated Apoptosis
Bennett, M., Macdonald, K., Chan, S.-W., Luzio, J. P., Simari, R., & Weissberg, P. (1998) · Science · doi:10.1126/science.282.5387.290 · Cited by 754
Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752
Self-citationChen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Tip60-Dependent Acetylation of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Tang, Y., Luo, J., Zhang, W., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.021 · Cited by 727
Role for the p53 homologue p73 in E2F-1-induced apoptosis
Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600 · cited 1×
“Recent studies in mice have now formally proven that restoration of p53 function in tumor cells lacking p53 can restore tumor suppression (Martins et al., 2006).”
Backgroundp73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release
Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P., & Green, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7337 · Cited by 560
p73: Friend or foe in tumorigenesis
Melino, G., De Laurenzi, V., & Vousden, K. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc861 · Cited by 560
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 546
PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Cloning and functional analysis of human p51, which structurally and functionally resembles p53
Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-839 · Cited by 529
Murray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 515
Flores, E. R., Sengupta, S., Miller, J. B., Newman, J. J., Bronson, R., Crowley, D., Yang, A., McKeon, F., & Jacks, T. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.019 · Cited by 502
Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1874-1887.2001 · Cited by 464
Bergamaschi, D., Gasco, M., Hiller, L., Sullivan, A., Syed, N., Trigiante, G., Yulug, I., Merlano, M., Numico, G., Comino, A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00079-5 · Cited by 449
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
Rocco, J. W., Leong, C.-O., Kuperwasser, N., DeYoung, M. P., & Ellisen, L. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.013 · Cited by 433
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
Strano, S., Munarriz, E., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G., & Blandino, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010484200 · Cited by 422
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
Chemosensitivity linked to p73 function
Irwin, M. S., Kondo, K., Marin, M. C., Cheng, L. S., Hahn, W. C., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00078-3 · Cited by 408
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 379
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human
Bergamaschi, D., Samuels, Y., O'Neil, N. J., Trigiante, G., Crook, T., Hsieh, J.-K., O'Connor, D. J., Zhong, S., Campargue, I., Tomlinson, M. L., et al. (2003) · Nature Genetics · doi:10.1038/ng1070 · Cited by 371
Han, M.-K., Song, E.-K., Guo, Y., Ou, X., Mantel, C., & Broxmeyer, H. E. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.002 · Cited by 368
p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation
Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., & Vousden, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307469200 · Cited by 368
Erster, S., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 368
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.008 · Cited by 360
Levy, D., Adamovich, Y., Reuven, N., & Shaul, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.022 · Cited by 347
Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53
Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Lüthi, A. U., Pirnia, F., Hügli, B., Graber, H. U., De Laurenzi, V, Fey, M. F., et al. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400962 · Cited by 341
POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells.
Gan, L., Xiang, M., Zhou, L., Wagner, D. S., Klein, W. H., & Nathans, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3920 · Cited by 333
Multiple roles of the tumor suppressor p53
Bargonetti, J., & Manfredi, J. J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00015 · Cited by 332
Westfall, M. D., Mays, D. J., Sniezek, J. C., & Pietenpol, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2264-2276.2003 · Cited by 330
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
Strom, E., Sathe, S., Komarov, P. G., Chernova, O. B., Pavlovska, I., Shyshynova, I., Bosykh, D. A., Burdelya, L. G., Macklis, R. M., Skaliter, R., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio809 · Cited by 327
DNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes
Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P. A., Fontemaggi, G., Fanciulli, M., Schiltz, L., Blandino, G., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00431-8 · Cited by 319
Perp Is a p63-Regulated Gene Essential for Epithelial Integrity
Ihrie, R. A., Marques, M. R., Nguyen, B. T., Horner, J. S., Papazoglu, C., Bronson, R. T., Mills, A. A., & Attardi, L. D. (2005) · Cell · doi:10.1016/j.cell.2005.01.008 · Cited by 311
p63 deficiency activates a program of cellular senescence and leads to accelerated aging
Keyes, W. M., Wu, Y., Vogel, H., Guo, X., Lowe, S. W., & Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.342305 · Cited by 298
Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., & Yoshida, K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.007 · Cited by 295
Dohn, M., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 294
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Knights, C. D., Catania, J., Giovanni, S. D., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512059 · Cited by 287
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286
A novel protein with strong homology to the tumor suppressor p53
Schmale, H., & Bamberger, C. (1997) · Oncogene · doi:10.1038/sj.onc.1201500 · Cited by 283
Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 280
Functional regulation of p73 and p63: development and cancer
Melino, G. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.004 · Cited by 278
Differential regulation of E2F1 apoptotic target genes in response to DNA damage
Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb998 · Cited by 266
p63 and p73 in human cancer: defining the network
DeYoung, M. P., & Ellisen, L. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210337 · Cited by 266
Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer
Urist, M. J., Di Como, C. J., Lu, M.-L., Charytonowicz, E., Verbel, D., Crum, C. P., Ince, T. A., McKeon, F. D., & Cordon-Cardo, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64396-9 · Cited by 257
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600708 · Cited by 255
Tomita, Y., Marchenko, N., Erster, S., Nemajerova, A., Dehner, A., Klein, C., Pan, H., Kessler, H., Pancoska, P., & Moll, U. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507611200 · Cited by 248
Le Cam, L., Linares, L. K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., Triboulet, R., Bossis, G., Shmueli, A., Rodriguez, M. S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.031 · Cited by 240
Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J., & Sidransky, D. (1998) · Nature Medicine · doi:10.1038/nm0798-747 · Cited by 238
Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response
Wei, X., Xu, H., & Kufe, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.008 · Cited by 234
Xiang, M., Gan, L., Zhou, L., Klein, W. H., & Nathans, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11950 · Cited by 233
ASPP1 and ASPP2: Common Activators of p53 Family Members
Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lu, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 228
Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities
Strano, S., Fontemaggi, G., Costanzo, A., Rizzo, M. G., Monti, O., Baccarini, A., Del Sal, G., Levrero, M., Sacchi, A., Oren, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201405200 · Cited by 226
p53 family update: p73 and p63 develop their own identities.
Irwin, M. S., & Kaelin, W. G. (2001) · PubMed · Cited by 222
Wu, G., Nomoto, S., Hoque, M. O., Dracheva, T., Osada, M., Lee, C. R., Dong, S. M., Guo, Z., Benoit, N. E., Cohen, Y., et al. (2003) · PubMed · Cited by 221
The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73
Levy, D., Adamovich, Y., Reuven, N., & Shaul, Y. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402063 · Cited by 210
Frequent alteration of p63 expression in human primary bladder carcinomas.
Park, B.-J., Lee, S. J., Kim, J. I., Lee, S., Lee, C. H., Chang, S. G., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 209
Michalak, E. M., Villunger, A., Adams, J. M., & Strasser, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.16 · Cited by 205
FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity
Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W., & Gu, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609001200 · Cited by 203
Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
Kawano, S., Cw, M., Gombart, A., Bartram, C., Matsuo, Y., Asou, H., Sakashita, A., Said, J. W., Tatsumi, E., & Koeffler, H. P. (1999) · PubMed · doi:10.1182/blood.v94.3.1113.415k33_1113_1120 · Cited by 189
Pin1 Links the Activities of c-Abl and p300 in Regulating p73 Function
Mantovani, F., Piazza, S., Gostissa, M., Strano, S., Zacchi, P., Mantovani, R., Blandino, G., & Del Sal, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.007 · Cited by 181
Koga, F., Kawakami, S., Fujii, Y., Saito, K., Ohtsuka, Y., Iwai, A., Ando, N., Takizawa, T., Kageyama, Y., & Kihara, K. (2003) · PubMed · Cited by 181
Mantovani, F., Tocco, F., Girardini, J. E., Smith, P., Gasco, M., Lü, X., Crook, T., & Sal, G. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1306 · Cited by 177
Kaelin, W. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202955 · Cited by 174
Sansome, C., Zaika, A., Marchenko, N. D., & Moll, U. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02368-1 · Cited by 174
Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., & Soddu, S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.008 · Cited by 174
Transactivation-deficient ΔTA-p73 Inhibits p53 by Direct Competition for DNA Binding
Stiewe, T., Theseling, C. C., & Pützer, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200480200 · Cited by 173
Müller, M., Schilling, T., Sayan, A. E., Kairat, A., Lorenz, K., Schulze-Bergkamen, H., Oren, M., Koch, A., Tannapfel, A., Stremmel, W., et al. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401774 · Cited by 171
One, two, three—p53, p63, p73 and chemosensitivity
MULLER, M., Schleithoff, E. S., Stremmel, W., Melino, G., Krammer, P. H., & Schilling, T. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2007.01.001 · Cited by 165
Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation
Das, S., Raj, L., Zhao, B., Kimura, Y., Bernstein, A., Aaronson, S. A., & Lee, S. W. (2007) · Cell · doi:10.1016/j.cell.2007.06.013 · Cited by 158
Essential Role for Caspase-8 in Transcription-independent Apoptosis Triggered by p53
Ding, H., Lin, Y., McGill, G. G., Juo, P., Zhu, H., Blenis, J., Yuan, J., & Fisher, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004714200 · Cited by 146
Oncogenes Induce and Activate Endogenous p73 Protein
Zaika, A. I., Irwin, M. S., Sansome, C., & Moll, U. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005737200 · Cited by 143
Ser46 Phosphorylation Regulates p53-Dependent Apoptosis and Replicative Senescence
Feng, L., Hollstein, M., & Xu, Y. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3526 · Cited by 140
Concin, N., Becker, K., Slade, N., Erster, S. H., Mueller-Holzner, E., Ulmer, H., Daxenbichler, G., Zeimet, A. G., Zeillinger, R., Marth, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1060 · Cited by 138
Luo, J., Yang, Q., Tong, W., Hergenhahn, M., Wang, Z., & Hollstein, M. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204080 · Cited by 135
Johnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 134
Tumor-Specific p73 Up-regulation Mediates p63 Dependence in Squamous Cell Carcinoma
DeYoung, M. P., Johannessen, C. M., Leong, C., Faquin, W. C., Rocco, J. W., & Ellisen, L. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1619 · Cited by 133
Dominant Negative p63 Isoform Expression in Head and Neck Squamous Cell Carcinoma
Sniezek, J. C., Matheny, K. E., Westfall, M. D., & Pietenpol, J. A. (2004) · The Laryngoscope · doi:10.1097/01.mlg.0000149437.35855.4b · Cited by 132
Chao, C., Wu, Z., Mazur, S. J., Borges, H. L., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., & Xu, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-06 · Cited by 130
p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop
Kartasheva, N. N., Contente, A., Lenz-Stöppler, C., Roth, J. C., & Dobbelstein, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205584 · Cited by 127
Yan, Y., Shay, J. W., Wright, W. E., & Mumby, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15220 · Cited by 117
Regulation of p73 by c-Abl through the p38 MAP kinase pathway
Sánchez‐Prieto, R., Lobo, V. J. S.-A., Servitja, J., & Gutkind, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205134 · Cited by 113
Defining the p53 DNA‐binding domain/Bcl‐xL‐binding interface using NMR
Petros, A. M., Gunasekera, A. H., Xu, N., Olejniczak, E. T., & Fesik, S. W. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00059-6 · Cited by 112
Domínguez, G., García, J. M., Peña, C., Silva, J., García‐Barberán, V., Martínez, L., Maximiano, C., Gomez, M. E., Rivera, J. A., García-Andrade, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2350 · Cited by 112
p53 family members in myogenic differentiation and rhabdomyosarcoma development
Çam, H., Griesmann, H., Beitzinger, M., Hofmann, L., Beinoravičiūtė-Kellner, R., Sauer, M., Hüttinger-Kirchhof, N., Oswald, C., Friedl, P., Gattenlöhner, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.024 · Cited by 109
Hashimoto, T., Tokuchi, Y., Hayashi, M., Kobayashi, Y., 西田, 一., Hayashi, S., Ishikawa, Y., Tsuchiya, S., Nakagawa, K., Hayashi, J., et al. (1999) · PubMed · Cited by 109
Oligomerization of BAK by p53 Utilizes Conserved Residues of the p53 DNA Binding Domain
Pietsch, E. C., Perchiniak, E. M., Canutescu, A. A., Wang, G., Dunbrack, R. L., & Murphy, M. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710539200 · Cited by 108
Self-citationZeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 101
p73 is transcriptionally regulated by DNA damage, p53, and p73
Chen, X., Zheng, Y., Zhu, J., Jiang, J., & Wang, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204149 · Cited by 96
Petitjean, A., Ruptier, C., Tribollet, V., Hautefeuille, A. H., Chardon, F., Cavard, C., Puisieux, A., Hainaut, P. L., & de Fromentel, C. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm258 · Cited by 93
Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System
Ding, H., McGill, G. G., Rowan, S., Schmaltz, C., Shimamura, A., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28378 · Cited by 90
p51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation
Katoh, I., Aisaki, K., Kurata, S., Ikawa, S., & Ikawa, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203644 · Cited by 90
Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma
LEITAO, M., Soslow, R. A., Baergen, R. N., Olvera, N., ARROYO, C., & Boyd, J. A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.043 · Cited by 88
p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors
Keyes, W. M., Vogel, H. S., Koster, M. I., Guo, X., Qi, Y., Petherbridge, K. M., Roop, D. R., Bradley, A., & Mills, A. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602477103 · Cited by 88
Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo
Talos, F., Petrenko, O., Mena, P., & Moll, U. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1084 · Cited by 88
p63 and p73 are not required for the development and p53-dependent apoptosis of T cells
Senoo, M., Manis, J. P., Alt, F. W., & McKeon, F. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.005 · Cited by 81
Weber, A., Bellmann, U., Bootz, F., Wittekind, C., & Tannapfel, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10296 · Cited by 79
Stefano, V. D., Soddu, S., Sacchi, A., & D’Orazi, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208717 · Cited by 78
Peptidyl‐prolyl cis/trans isomerases and transcription: is there a twist in the tail?
Shaw, P. E. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400873 · Cited by 69
Hudson, C. D., Morris, P. J., Latchman, D. S., & Budhram-Mahadeo, V. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408679200 · Cited by 68
Sot, B., Freund, S. M. V., & Fersht, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705544200 · Cited by 65
p73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis
Sayan, E., Sayan, B. S., Gogvadze, V. G., Dinsdale, D. D., Nyman, U., Hansen, T. M., Zhivotovsky, B., Cohen, G. M., Knight, R. A., & Melino, G. (2008) · Oncogene · doi:10.1038/onc.2008.64 · Cited by 63
Dietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 60
Okada, Y., Osada, M., Kurata, S., Sato, S., Aisaki, K., Kageyama, Y., Kihara, K., Ikawa, Y., & Katoh, I. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5535 · Cited by 55
Hayes, V. M., Dirven, C. M. F., Dam, A., Verlind, E., Molenaar, W. M., Mooij, J. J. A., Hofstra, R. M. W., & Buys, C. H. C. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00535.x · Cited by 51
p53 Mutations in Benign Prostatic Hyperplasia
Meyers, F. J., Chi, S.-G., Fishman, J. R., White, R. D., & Gumerlock, P. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.22.1856 · Cited by 48
p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms.
Haupt, Y., Rowan, S., Shaulian, E., Kazaz, A., Vousden, K. H., & Oren, M. (1997) · PubMed · Cited by 48
Wager, M., Guilhot, J., Blanc, J.-L., Ferrand, S., Milin, S., Bataille, B., Lapierre, F., Denis, S., Chantereau, T., Cj, L., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603410 · Cited by 42
Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis
Sayan, B. S., Sayan, E., Yang, A. L., Aqeilan, R. I., Candi, E., Cohen, G. M., Knight, R. A., Croce, C. M., & Melino, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700761104 · Cited by 42
Johnson, T. M., Meade, K. E., Pathak, N., Marques, M. R., & Attardi, L. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706764105 · Cited by 40
Budhram-Mahadeo, V. S., Bowen, S., Lee, S., Perez-Sanchez, C., Ensor, E. A., Morris, P. J., & Latchman, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl878 · Cited by 38
TAp73 Is a Downstream Target of p53 in Controlling the Cellular Defense against Stress
Wang, J., Liu, Y., Hande, M. P., Wong, A. C., Jin, Y. J., & Yin, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703408200 · Cited by 35
Helton, E. S., Zhang, J., & Chen, X. (2007) · Oncogene · doi:10.1038/sj.onc.1210948 · Cited by 33
Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
Palacios, G. F., & Moll, U. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209641 · Cited by 32
Nemajerová, A., Wolff, S., Petrenko, O., & Moll, U. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.074 · Cited by 21
Deißler, H., Kafka, A., Schuster, E., Sauer, G., Kreienberg, R., & Zeillinger, R. (2004) · Oncology Reports · doi:10.3892/or.11.6.1281 · Cited by 20
Zeng, X., Zhu, Y., & Lu, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.2.215 · Cited by 19
Cited by
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
DNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
p53 — a Jack of all trades but master of none
Junttila, M. R., & Evan, G. I. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2728 · Cited by 345
The Origins and Evolution of the p53 Family of Genes
Belyi, V. A., Ak, P., Markert, E., Wang, H., Hu, W., Puzio-Kuter, A., & Levine, A. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001198 · Cited by 292
The mitochondrial death pathway: a promising therapeutic target in diseases
Gupta, S., Kass, G. E. N., Szegezdi, E., & Joseph, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00697.x · Cited by 278
Metadata
- Authors
- Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E.
- Venue
- Oncogene
- Published
- 2008-10-27
- Volume
- 27
- Issue
- 50
- Pages
- 6507-6521
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2063131548
- Cited by
- 315
- References
- 162
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.